Flinton Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$306K Hold
8,816
0.01% 582
2019
Q2
$279K Buy
8,816
+1,504
+21% +$44.7K 0.01% 620
2019
Q1
$219K Buy
7,312
+1,408
+24% +$40.4K 0.01% 659
2018
Q4
$182K Hold
5,904
0.01% 671
2018
Q3
$224K Sell
5,904
-25,872
-81% -$979K 0.01% 685
2018
Q2
$1.22M Buy
31,776
+7,696
+32% +$259K 0.04% 279
2018
Q1
$812K Buy
24,080
+17,632
+273% +$677K 0.03% 319
2017
Q4
$286K Sell
6,448
-576
-8% -$26.2K 0.01% 571
2017
Q3
$352K Buy
7,024
+832
+13% +$42.5K 0.01% 473
2017
Q2
$327K Buy
6,192
+288
+5% +$15.4K 0.01% 461
2017
Q1
$328K Buy
5,904
+240
+4% +$13.2K 0.01% 413
2016
Q4
$295K Buy
+5,664
New +$273K 0.01% 394

Other funds holding PBH

Flinton Capital Management's PBH Position: Q3 2019 in Review

Flinton Capital Management held its Prestige Consumer Healthcare (PBH) position steady in Q3 2019 at 8,816 shares worth $306K. The position accounts for 0.01% of the portfolio, ranked #582.

Flinton Capital Management first reported a position in PBH in Q4 2016 and has held it in 12 quarters since. The position peaked at $1.22M in Q2 2018. 230 funds tracked by Wall St. Rank hold PBH as of Q3 2019.

  • Flinton Capital Management held 8,816 shares of Prestige Consumer Healthcare worth $306K as of Q3 2019.
  • Flinton Capital Management left its Prestige Consumer Healthcare share count unchanged in Q3 2019.
  • Prestige Consumer Healthcare made up 0.01% of Flinton Capital Management's portfolio in Q3 2019, its #582 holding.
  • Flinton Capital Management first reported a position in Prestige Consumer Healthcare in Q4 2016 and has held it in 12 quarters since.
  • Flinton Capital Management's Prestige Consumer Healthcare position peaked at $1.22M in Q2 2018.
  • 230 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.